Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2655 of 3330
Next
>>
>
66351 to 66375 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
184B5	NM	Basal	Sirolimus	MTOR	MTOR	0.0107	uM	7789.068	0.8533	0.2219	0.3219
184B5	NM	Basal	Sirolimus	MTOR	MTOR	0.0533	uM	7789.068	0.6704	-0.4225	0.3219
184B5	NM	Basal	Sirolimus	MTOR	MTOR	0.267	uM	7789.068	0.6922	-0.3620	0.3219
184B5	NM	Basal	Sirolimus	MTOR	MTOR	1.33	uM	7789.068	0.6478	-0.4808	0.3219
184B5	NM	Basal	Sirolimus	MTOR	MTOR	6.67	uM	7789.068	0.8556	0.2319	0.3219
184B5	NM	Basal	Sirolimus	MTOR	MTOR	33.3	uM	7789.068	0.6789	-0.3995	0.3219
184B5	NM	Basal	Sirolimus	MTOR	MTOR	167	uM	7789.068	0.3392	-0.9304	0.3219
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	0.000427	uM	5899.068	1.0295	1.0567	1.0389
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	0.00213	uM	5899.068	0.9983	0.9967	1.0389
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	0.0107	uM	5899.068	0.9806	0.9627	1.0389
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	0.0533	uM	5899.068	0.8464	0.7034	1.0389
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	0.267	uM	5899.068	0.8233	0.6586	1.0389
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	1.33	uM	5899.068	0.8478	0.7061	1.0389
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	6.67	uM	5899.068	0.7818	0.5781	1.0389
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	33.3	uM	5899.068	0.8464	0.7034	1.0389
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	167	uM	5899.068	0.7837	0.5818	1.0389
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	0.000427	uM	7791.068	0.9810	0.9527	0.8032
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	0.00213	uM	7791.068	0.8868	0.7220	0.8032
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	0.0107	uM	7791.068	0.8946	0.7409	0.8032
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	0.0533	uM	7791.068	0.7673	0.4382	0.8032
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	0.267	uM	7791.068	0.7491	0.3957	0.8032
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	1.33	uM	7791.068	0.7431	0.3820	0.8032
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	6.67	uM	7791.068	0.7726	0.4505	0.8032
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	33.3	uM	7791.068	0.7787	0.4648	0.8032
600MPE	HR+	Luminal	Sirolimus	MTOR	MTOR	167	uM	7791.068	0.5634	-0.0209	0.8032

|<
<<
Previous
Page 2655 of 3330
Next
>>
>
66351 to 66375 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)